3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Rectal Neoplasms
9
Triple Negative Breast Neoplasms
7
Stomach Neoplasms
7
Colorectal Neoplasms
6
Adenocarcinoma
6
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Neoplasms
3
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Biliary Tract Neoplasms
2
Advanced Solid Tumour
2
Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Locally Advanced Gastric Cancer
1
HIV Infections
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Cyclophosphamide
3
fludarabine
2
Paclitaxel
2
Carboplatin
2
Bevacizumab
2
trastuzumab deruxtecan
1
pembrolizumab
1
olaparib
1
niraparib
1
mirvetuximab soravtansine
1
irinotecan sucrosofate
1
fludarabine phosphate
1
denileukin diftitox
1
Tinzaparin
1
Propranolol
1
Palliative Care
1
Nivolumab
1
Neoadjuvant Therapy
1
Music Therapy
1
Losartan
1
Indocyanine Green
1
GEN-1
1
Etodolac
1
E7777 fusion protein
1
Clarithromycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Capecitabine
×
30 days
×
Clear all
No trials found.